Where does BioSig Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioSig Technologies, Inc. ranks #11,574 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioSig Technologies, Inc. hold?

BioSig Technologies, Inc. holds 26 US utility patents granted between 2019 and 2024, spanning 10 technology areas.

What is BioSig Technologies, Inc.'s Innovation Score?

BioSig Technologies, Inc. has an Innovation Score of 37.5 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does BioSig Technologies, Inc. focus on?

BioSig Technologies, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 23 patents, ranking #784 of 7,127 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is BioSig Technologies, Inc.'s patent grant rate increasing or decreasing?

BioSig Technologies, Inc.'s recent grant velocity is +233% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for BioSig Technologies, Inc.'s patents?

BioSig Technologies, Inc.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioSig Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioSig Technologies, Inc.

USPTO PatentsView assignee record - 26 granted patents across 10 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biosig ranks #11,574 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 10 technology areas.

#11,574
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.5/100): 16.8
avg claims per patent: +233%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11574 · US Corporation #11,574 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,574/49,997
PHOTO-FINISH Bard Shannon
CPC-FOCUS A61B · 10 areas
INNOV-THIN 37.5/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +233% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bard Shannon Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biosig’s 37.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (30%) Velocity 4.9 pts (13%) Breadth 11.2 pts (30%) Claim depth 10.1 pts (27%)

Qualcomm Incorporated · highest

85
Clariant · near

38
BioSig · this assignee

38
P4tents1 · near

38
Rotation Medical · near

38
Understory · near

38
3D Lighting… · lowest

7

What this shows Biosig's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biosig?

Each dot is one of Biosig’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biosig’s own 16.8 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biosig vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biosig's grants concentrate

BioSig Technologies, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 88.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (6 grants) versus a trough of 2 in 2024. By volume, Biosig sits between Bard Shannon Limited and Brock USA, LLC.

Biosig's three-year grant acceleration

BioSig Technologies, Inc. shows 11 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bard Shannon

26
Baumueller Nuernb…

26
Belden

26
Bio-rad Europe

26
Bock 1 & KG

26
Braze

26
Brilliant Home Te…

26
Brock USA

26
Biosig ◀

26

What this shows BioSig holds 26 patents at rank #11,580, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioSig

By rank, the assignees closest to #11,580 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in BioSig's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for BioSig, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), BioSig ranks #784 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

P4tents1 LLC 38 Rotation Medical, Inc. 38 Understory, Inc. 38 Clariant Corporation 38

Biosig's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

BioSig Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	6	23.1%
2020	4	15.4%
2021	5	19.2%
2022	3	11.5%
2023	6	23.1%
2024	2	7.7%

Which technologies does BioSig Technologies, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 23

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 18

H03K - Pulse Technique 17

H01L - Semiconductor Devices NOT Covered BY Class H10 17

H02H - Emergency Protective Circuit Arrangements 17

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 17

H03F - Amplifiers 17

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 3

H03H - Impedance Networks, e.g. Resonant CIRCUITS; Resonators 3

H04B - Transmission 3

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioSig Technologies, Inc.'s patent record in context - here's where to go next.

BioSig Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 88.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,574 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioSig Technologies, Inc. against Bard Shannon Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.